COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2247: Articles 22461-22470  | Next

Estimation of the Basic Reproduction Number of SARS-CoV-2 in Bangladesh Using Exponential Growth Method
Mahmud, R., Patwari, H. M. A. F.
10.1101/2020.09.29.20203885 — Posted: 2020-09-29
Which early indicator allows for a better understanding of the evolution of the COVID-19 epidemic in France?
Loisel, P.
10.1101/2020.09.29.20203760 — Posted: 2020-09-29
Predictors of symptomatic laboratory-confirmed SARS-COV-2 reinfection
MURILLO-ZAMORA, E., HERNANDEZ-SUAREZ, C. M., LUGO-RADILLO, A., AGUILAR-SOLLANO, F., MENDOZA-CANO, O.
10.1101/2020.09.28.20203190 — Posted: 2020-09-29
DeepCOVID: An Operational Deep Learning-driven Framework for Explainable Real-time COVID-19 Forecasting
Rodriguez, A., Tabassum, A., Cui, J., Xie, J., Ho, J., Agarwal, P., Adhikari, B., Prakash, B. A.
10.1101/2020.09.28.20203109 — Posted: 2020-09-29
Cardiovascular disease and severe hypoxemia associated with higher rates of non-invasive respiratory support failure in COVID-19
Wang, J. G., Liu, B., Percha, B., Pan, S., Goel, N., Mathews, K., Gao, C., Tandon, P., Tomlinson, M., Yoo, E., Howell, D., Eisenberg, E., Naymagon, L., Tremblay, D., Chokshi, K., Dua, S., Dunn, A., Powell, C., Bose, S.
10.1101/2020.09.27.20202747 — Posted: 2020-09-29
Assessment of Commercial SARS-CoV-2 Antibody Assays, Jamaica
Butterfield, T. R., Bruce-Mowatt, A., Phillips, Y. Z. R., Brown, N., Francis, K., Brown, J., Taylor, D., Bruce, C. A., McGrowder, D., Wharfe, G., Sandiford, S. L., Thompson, T. K., Anzinger, J. J.
10.1101/2020.09.27.20202655 — Posted: 2020-09-29
Heat-based N95 mask decontamination and reuse in a large hospital setting
Vora, T., Bhattacharya, A., Ghosh, S., Gowda, K., Dhanaki, N., Gala, R., Dubey, N., Raut, V., Laskar, S. G., Sengar, M., Prakash, G., Singh, V. K., Chinnaswamy, G., Pramesh, C. S.
10.1101/2020.09.28.20203067 — Posted: 2020-09-29
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Ogbe, A., Kronsteiner, B., Skelly, D. T., Pace, M., Brown, A., Adland, E., Adair, K., Akhter, H. D., Ali, M., Ali, S.-E., Angyal, A., Ansari, M. A., Arancibia-Carcamo, C. V., Brown, H., Chinnakannan, S., Conlon, C. P., de Lara, C., de Silva, T., Dold, C., Dong, T. D., Donnison, T., Eyre, D. W., Flaxman, A., Fletcher, H. A., Gardner, J., Grist, J. T., Hackstein, C.-P., Jaruthamsophon, K., Jeffrey, K., Lambe, T., Lee, L., Li, W., Lim, N., Matthews, P. C., Mentzer, A. J., Moore, S. C., Naisbitt, D. J., Ogese, M., Ogg, G., Openshaw, P., Pirmohamed, M., Pollard, A. J., Ramamurthy, N., Rongkard, P., Rowland-Jones, S., Sampson, O. L., Screaton, G., Sette, A., Stafford, L., Thompson, C., Thomson, P. J., Thwaites, R., Vieira, V., Weiskopf, D., Zacharopoulou, P., Oxford Immunology Network Covid-19 Response T cell Consortium, , Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team, , Turtle, L., Klenerman, P., Goulder, P., Frater, J., Barnes, E., Dunachie, S.
10.1101/2020.09.28.20202929 — Posted: 2020-09-29 Discussion: Offsite
Transfer transcriptomic signatures for infectious diseases
di Iulio, J., Bartha, I., Spreafico, R., Virgin, H. W., Telenti, A.
10.1101/2020.09.28.20203406 — Posted: 2020-09-29
Two Color Single Molecule Sequencing on GenoCare 1600 Platform to Facilitate Clinical Applications
Chen, F., Liu, B., Chen, M., Jiang, Z., Zhou, Z., Wu, P., Zhang, M., Jin, H., Li, L., Lu, L., Wang, Q., Shang, H., Xie, B., Liu, L., Lin, X., Chen, W., Xu, J., Sun, R., Wang, G., Zheng, J., Qi, J., Yang, B., Chen, D., Zeng, L., Li, G., Li, Y., Lv, H., Zhao, N., Zhou, B., Wang, W., Cai, J., Liu, S., Luo, W., Zhang, J., Zhang, Y., Lu, Y., Fan, J., Dan, H., He, X., Liu, L., Feng, Y., Chen, J., Huang, W., Sun, L., Yan, Q.
10.1101/2020.09.28.20203455 — Posted: 2020-09-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).